The next time you need a tablet to relieve your hypertension problems, you may want to try out the new Ramipril tablets instead of the Altace tablets. Lupin limited, a well known pharmaceuticals based in Bombay has managed to get the final go ahead to introduce their version of the Altace tablets to the American markets. Lupin decided to come out with their own generic version of the age old Altace and in spite of legal hurdles initiated by King pharmaceuticals they have managed to prevail.

The new version of the Altace tablets offers the American consumers a much better alternative when it comes alleviating their hypertension problems. For one, it is alleged to be quicker than the old version and is priced competitively. The US Food and Drug administration has granted its approval of the Ramipril capsules in the 1.25 mg, 2.5mg, 5mg and the 10 mg varieties.

Lupin has become the very first company to successfully challenge the hold that Altace tablets have had on the American consumer market and win it. The new and the generic form of the old meds forbears interesting times ahead with more generic forms of old formulas due to hit the markets in the near future. The patients as well as the American markets are set to benefit as a result of new entrants like Ramipril on account of their effectiveness as well as the range of prices they offer. With effective medicine being made available, one can hope that the burden on the American healthcare would decrease with time.

Tags: altace, america, asia, generic variants, hypertension, king, lupin, medicine, ramipril, tablets

This entry was posted on Thursday, June 12th, 2008 at 10:03 pm and is filed under bio technology, medicine, science. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.